RECENT NEWS
Boots to pilot diabetes screening with the LumiraDx HbA1c test
National pharmacy retail chain Boots has announced a UK-wide diabetes screening pilot which will offer a private screening service to customers using the LumiraDx platform and HbA1c test.
Bio-Rad launches new thermal cyclers
Bio-Rad Laboratories has launched the new PTC Tempo 96 and PTC Tempo Deepwell thermal cyclers, designed to optimise PCR applications such as sequencing, cloning, and genotyping.
Proxim Diagnostics announces bioMérieux investment
Proxim Diagnostics, a company developing a handheld, point-of care diagnostic device, announced it has received a strategic investment from bioMérieux, a world leader in the field of in vitro diagnostics.
MHRA to streamline clinical trial approvals
A series of new measures will be introduced by the Medicines and Healthcare products Regulatory Agency (MHRA) with support from partners to make it faster and easier to gain approval and to run clinical trials in the UK.
PerkinElmer completes move to life sciences and diagnostics company
PerkinElmer has successfully completed the previously announced divestiture of its applied, food and enterprise services businesses to New Mountain Capital, a growth-oriented investment firm.
Proscia strengthens position in preclinical R&D
Proscia, a leading provider of digital and computational pathology solutions, has strengthened its position in the $12 billion preclinical research and development (R&D) market with enhancements to its flagship Concentriq for Research platform.
Novel NAD blood test launched in US
NADMED, a start-up that offers kits and laboratory services for the measurement of NADs from any biological sample, has announced a partnership with health data company and CLIA-certified laboratory TruDiagnostic to launch a novel NAD blood test in the United States.
More advanced diagnostic testing crucial to prevent an avian influenza pandemic
Dr Nicole Robb, Assistant Professor at Warwick University, Oxford University lecturer, and co-founder of healthtech company Pictura Bio, has today warned that the UK’s diagnostic testing capabilities are not advanced enough to deal with an influenza spill-over event from birds to humans quickly and efficiently. Dr Robb believes that new diagnostic technologies are needed as a priority.
INTEGRA Biosciences acquires Miroculus to accelerate genomics
INTEGRA Biosciences has acquired Miroculus, a biotechnology specialist focused on developing hands-off automation solutions for next generation sequencing (NGS) protocols.
CF AMR Syndicate launches £3 million discovery programme
Cystic Fibrosis (CF) Syndicate in Antimicrobial Resistance (AMR) has launched a £3 million Collaborative Discovery Programme for drug discovery innovators to accelerate the development of new treatments for people with CF.
London Medical Laboratory deploys Cirdan’s next-generation LIS
London Medical Laboratory (LML) has improved its efficiency and enhanced annual revenue growth by deploying Cirdan’s next-generation laboratory information system, ULTRA. ULTRA improves the quality of patient care by delivering more timely and accurate results to both clinicians and patients.
MHRA to receive £10m to fast-track access to cutting-edge medical products
HM Treasury has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) will receive £10 million to help bring innovative new medicines and medical technologies to UK patients more quickly.
Chancellor announces MHRA reforms
In his Spring Budget today, 15 March, the Chancellor of the Exchequer, Jeremy Hunt has announced future changes for the Medicines and Healthcare products Regulatory Agency (MHRA).
Owlstone Medical partners with Bicycle Therapeutics for early cancer detection
Owlstone Medical the developer of Breath Biopsy for applications in early disease detection and precision medicine, has entered into a research agreement with Bicycle Therapeutics, a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology.
Aiosyn launches AI-powered QC for digital pathology workflow
Aiosyn, a software company that develops AI-powered pathology software, has launched its first product that assists digital pathology labs across research, diagnostics and pharma to improve their quality control (QC) process.
UKTLC revises minimum standards for 2023
The UK Transfusion Laboratory Collaborative (UKTLC) has revised its minimum standards for 2023, with an abridged version now available on the Serious Hazards Of Transfusion (SHOT) website.
Advancing Healthcare Awards unveils shortlist
The 2023 Advancing Healthcare Awards has unveiled its shortlist ahead of the awards lunch and presentation ceremony taking pace on 21 April. The awards recognise and celebrate the work of allied health professionals, healthcare scientists and those who work alongside them in support roles, leading innovative healthcare practice across the UK.
Thermo Fisher Scientific Microbiology’s ISO 17034 certification assures reliable reference materials
Thermo Fisher Scientific Microbiology has achieved International Organization for Standardization (ISO) 17034 certification, making it an accredited reference material (RM) manufacturer of certified reference material (CRM) quality control products.
Paige and Leica Biosystems expand digital pathology partnership
Paige and Leica Biosystems have expanded their partnership to enhance the use of digital pathology workflows at hospitals and laboratories around the world. Building upon the existing partnership, Leica Biosystems has selected Paige as the preferred provider of software-as-a-service (SaaS) digital pathology image management and viewing software along with diverse embedded AI solutions for its line of Aperio GT 450 digital pathology slide scanners.
Spectrum Healthcare Partners turns to Proscia for cancer diagnosis
Proscia, a leading provider of digital and computational pathology solutions, has announced that Spectrum Healthcare Partners (SHCP), an independent, multispecialty, physician-owned healthcare practice, has selected Concentriq Dx to modernise its pathology operations.
Featured Supplier
Global Headquarters
Advanced Instruments, LLC
Two Technology Way
Norwood, MA 02062, United States
Phone: +1 800-225-4034
Advanced Instruments has been a leading developer and manufacturer of analytical instruments and services for the clinical, biopharmaceutical, and food & beverage industries for more than 65...
Upcoming Events
Participants’ Meeting: UK NEQAS Immunology, Immunochemistry & Allergy
Sheffield Hallam University, City Campus, Howard Street, Sheffield
24 May, 2024
Med-Tech Innovation Expo
NEC, Birmingham
5-6 June, 2024
UK NEQAS Blood Coagulation: Clinical and Laboratory Haemostasis 2024
Sheffield Hallam University
5-6 June, 2024
LabMedUK24
DoubleTree by Hilton Brighton Metropole
10-12 June, 2024
Infection Diagnostics Symposium 2024
IET Austin Court, Birmingham
26-27 June, 2024
SHOT Symposium 2024
Mercure Manchester Piccadilly Hotel
9 July, 2024
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store